Meropenem therapy in extracorporeal membrane oxygenation patients: an ongoing pharmacokinetic challenge

Documenti analoghi

• The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
  di: Honore, Patrick M, et al.
  Pubblicazione: (2015)
• Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
  di: Honore, Patrick M., et al.
  Pubblicazione: (2015)
• Intertwining extracorporeal membrane oxygenation and continuous renal replacement therapy: sense or nonsense?
  di: Jacobs, Rita, et al.
  Pubblicazione: (2015)
• ‘Biomarking’ infection during continuous renal replacement therapy: still relevant?
  di: Honore, Patrick M, et al.
  Pubblicazione: (2015)
• Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?
  di: Honore, Patrick M, et al.
  Pubblicazione: (2015)